Ecdysone Titer Determined by 3DE-3Β-Reductase Enhances The
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Investigation of RNA-Mediated Pathogenic Pathways in a Drosophila Model of Expanded Repeat Disease
Investigation of RNA-mediated pathogenic pathways in a Drosophila model of expanded repeat disease A thesis submitted for the degree of Doctor of Philosophy, June 2010 Clare Louise van Eyk, B.Sc. (Hons.) School of Molecular and Biomedical Science, Discipline of Genetics The University of Adelaide II Table of Contents Index of Figures and Tables……………………………………………………………..VII Declaration………………………………………………………………………………......XI Acknowledgements…………………………………………………………………........XIII Abbreviations……………………………………………………………………………....XV Drosophila nomenclature…………………………………………………………….….XV Abstract………………………………………………………………………………........XIX Chapter 1: Introduction ............................................................................................1 1.0 Expanded repeat diseases....................................................................................1 1.1 Translated repeat diseases...................................................................................2 1.1.1 Polyglutamine diseases .............................................................................2 Huntington’s disease...................................................................................3 Spinal bulbar muscular atrophy (SBMA) .....................................................3 Dentatorubral-pallidoluysian atrophy (DRPLA) ...........................................4 The spinal cerebellar ataxias (SCAs)..........................................................4 1.1.2 Pathogenesis and aggregate formation .....................................................7 -
(12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown Et Al
US 20030082511A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown et al. (43) Pub. Date: May 1, 2003 (54) IDENTIFICATION OF MODULATORY Publication Classification MOLECULES USING INDUCIBLE PROMOTERS (51) Int. Cl." ............................... C12O 1/00; C12O 1/68 (52) U.S. Cl. ..................................................... 435/4; 435/6 (76) Inventors: Steven J. Brown, San Diego, CA (US); Damien J. Dunnington, San Diego, CA (US); Imran Clark, San Diego, CA (57) ABSTRACT (US) Correspondence Address: Methods for identifying an ion channel modulator, a target David B. Waller & Associates membrane receptor modulator molecule, and other modula 5677 Oberlin Drive tory molecules are disclosed, as well as cells and vectors for Suit 214 use in those methods. A polynucleotide encoding target is San Diego, CA 92121 (US) provided in a cell under control of an inducible promoter, and candidate modulatory molecules are contacted with the (21) Appl. No.: 09/965,201 cell after induction of the promoter to ascertain whether a change in a measurable physiological parameter occurs as a (22) Filed: Sep. 25, 2001 result of the candidate modulatory molecule. Patent Application Publication May 1, 2003 Sheet 1 of 8 US 2003/0082511 A1 KCNC1 cDNA F.G. 1 Patent Application Publication May 1, 2003 Sheet 2 of 8 US 2003/0082511 A1 49 - -9 G C EH H EH N t R M h so as se W M M MP N FIG.2 Patent Application Publication May 1, 2003 Sheet 3 of 8 US 2003/0082511 A1 FG. 3 Patent Application Publication May 1, 2003 Sheet 4 of 8 US 2003/0082511 A1 KCNC1 ITREXCHO KC 150 mM KC 2000000 so 100 mM induced Uninduced Steady state O 100 200 300 400 500 600 700 Time (seconds) FIG. -
(12) Patent Application Publication (10) Pub. No.: US 2006/0128764 A1 Downes Et Al
US 2006O128764A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0128764 A1 DOWnes et al. (43) Pub. Date: Jun. 15, 2006 (54) NON-STEROIDAL FARNESOD X Publication Classification RECEPTOR MODULATORS AND METHODS FOR THE USE THEREOF (51) Int. Cl. A61K 31/4433 (2006.01) (75) Inventors: Michael R Downes, San Diego, CA A6II 3/44 (2006.01) (US); Ronald M Evans, La Jolla, CA A6II 3 L/353 (2006.01) (US) A6II 3/16 (2006.01) (52) U.S. Cl. ........................... 514/357: 514/456; 514/625 Correspondence Address: FOLEY & LARDNER LLP P.O. BOX 80278 (57) ABSTRACT SAN DIEGO, CA 92138-0278 (US) The efficient regulation of cholesterol synthesis, metabo (73) Assignee: THE SALK INSTITUTE FOR BIO lism, acquisition, and transport is an essential component of LOGICAL STUDES lipid homeostasis. The farnesoid X receptor (FXR) is a transcriptional sensor for bile acids, the primary product of (21) Appl. No.: 10/535,043 cholesterol metabolism. Accordingly, the development of potent, selective, Small molecule agonists, partial agonists, (22) PCT Fed: Nov. 14, 2003 and antagonists of FXR would be an important step in PCT No.: PCT/USO3/36137 further deconvoluting FXR physiology. In accordance with (86) the present invention, the identification of novel potent FXR Related U.S. Application Data activators is described. Two derivatives of invention com pounds, bearing stilbene or biaryl moieties, contain mem (60) Provisional application No. 60/426,664, filed on Nov. bers that are the most potent FXR agonists reported to date 15, 2002. in cell-based assays. These compounds are useful as chemi cal tools to further define the physiological role of FXR as (30) Foreign Application Priority Data well as therapeutic leads for the treatment of diseases linked to cholesterol, bile acids and their metabolism and homeo Sep. -
Ecdysone Oxidase and 3-Oxoecdysteroid Reductases in Manduca Sexta Midgut: Kinet I C Parameters
Archives of Insect Biochemistry and Physiology 12:201-218 (1 989) Ecdysone Oxidase and 3-Oxoecdysteroid Reductases in Manduca sexta Midgut: Kinet i c Parameters Gunter F. Weirich, Malcolm J. Thompson, and James A. Svoboda Insect Hormone Laboratory, Agricultural Research Service, United States Department of Agriculture, Beltsville, Maryland Ecdysone and 20-hydroxyecdysone are converted to their 3-epimers by enzymes in the midgut cytosol of Manduca sexta larvae. A partially purified cytosol preparation has been used to analyze the nature of and the interaction between these enzymes. The cytosol was shown to contain ecdysone oxidase, one or more 3-oxoecdysteroid 3wreductase(s), and one or more 3-oxoecdysteroid 3P-reductase(s). The reductases reacted at different velocities with NADH and NADPH. With NADH, 3a-reduction was the major reaction; with NADPH, 3P-reduction was the major reaction. The apparent kinetic parameters for the enzymes support the assumed two-step mechanism for the 3-epimerization with a 3-oxoecdysteroid as intermediate. Key words: 3-epimerizatior1, 3-dehydroecdysonef 3-epiecdysonef 3a-hydroxyecdysteroids, 3P-hydroxyecdysteroidsf NADH, NADPH, molting hormone inactivation INTRODUCTION 3-Epiecdysteroids (3a-hydroxyecdysteroids)have been isolated from several insect species [1,2]. Because of their low molting hormone activity [l-31 they are assumed to be inactivation products [2,4]. In vitro ecdysone 3-epimerization was first observed by Nigg et al. in incubations of ecdysone with midgut homog- enates of the tobacco hornworm, Manduca sexta L. [5]. The enzyme system for Acknowledgments: We thank Rosemary E. Hennessey and Lynda J. Liska for their dedicated technical assistance; and Drs. Govindan Bhaskaran, David J. -
12) United States Patent (10
US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S. -
Salehzadeh, Areaf (2002) Effects of Azadirachtin on Insect and Mammalian Cultured Cells. Phd Thesis
Salehzadeh, Areaf (2002) Effects of azadirachtin on insect and mammalian cultured cells. PhD thesis. http://theses.gla.ac.uk/3060/ Copyright and moral rights for this thesis are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Glasgow Theses Service http://theses.gla.ac.uk/ [email protected] Effects of azadirachtin on insect and mammalian cultured cells By Areaf Salehzadeh (M.Sc. Medical Entomology) (University of Tehran, Tehran, Iran) Thesis submitted for the Degree of Doctor of Philosophy July 2002 UNIVERSITY of GLASGOW Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow GI2 8QQ Scotland UK In the name of ALLAH Most gracious Most merciful Thanking Him With a full heart and devoted tongue II era My parents III Acknowledgement I would like to express my sincerest thanks to everyone who assisted me during the course of my work especially: Dr. R. H. C. Strang for his able guidance, unlimited encouragement and constructive criticism. It has been a great privilege to have worked with him. His co operation and support is highly appreciated; Prof. R. L. -
CYP18A1, a Key Enzyme of Drosophila Steroid Hormone Inactivation, Is Essential for Metamorphosis
Developmental Biology 349 (2011) 35–45 Contents lists available at ScienceDirect Developmental Biology journal homepage: www.elsevier.com/developmentalbiology CYP18A1, a key enzyme of Drosophila steroid hormone inactivation, is essential for metamorphosis Emilie Guittard a, Catherine Blais a, Annick Maria a, Jean-Philippe Parvy a, Shivani Pasricha b, Christopher Lumb b, René Lafont c, Phillip J. Daborn b, Chantal Dauphin-Villemant a,⁎ a Equipe Biogenèse des Signaux hormonaux, Laboratoire Biologie du Développement, UMR7622 CNRS, UPMC, 7 Quai St Bernard, F-75005 Paris, France b Department of Genetics, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria, 3010, Australia c Laboratoire BIOSIPE, ER3, UPMC, 7 Quai St Bernard, F-75005 Paris, France article info abstract Article history: Ecdysteroids are steroid hormones, which coordinate major developmental transitions in insects. Both the Received for publication 18 June 2010 rises and falls in circulating levels of active hormones are important for coordinating molting and Revised 28 September 2010 metamorphosis, making both ecdysteroid biosynthesis and inactivation of physiological relevance. We Accepted 28 September 2010 demonstrate that Drosophila melanogaster Cyp18a1 encodes a cytochrome P450 enzyme (CYP) with 26- Available online 7 October 2010 hydroxylase activity, a prominent step in ecdysteroid catabolism. A clear ortholog of Cyp18a1 exists in most Keywords: insects and crustaceans. When Cyp18a1 is transfected in Drosophila S2 cells, extensive conversion of 20- Cytochrome P450 enzyme hydroxyecdysone (20E) into 20-hydroxyecdysonoic acid is observed. This is a multi-step process, which Drosophila melanogaster involves the formation of 20,26-dihydroxyecdysone as an intermediate. In Drosophila larvae, Cyp18a1 is Growth expressed in many target tissues of 20E. -
Chapter 3. in Vivo Effects of Xenobiotic Exposures on Steroid Levels and Steroid Metabolism in Molluscs
CHAPTER 3. IN VIVO EFFECTS OF XENOBIOTIC EXPOSURES ON STEROID LEVELS AND STEROID METABOLISM IN MOLLUSCS. - 120 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 121 - Paper 5 EFFECTS OF 17-ESTRADIOL EXPOSURE IN THE MUSSEL MYTILUS GALLOPROVINCIALIS: THE REGULATING ROLE OF STEROID ACYLTRANSFERASES. Gemma Janer, Ramon Lavado, Rémi Thibaut, Cinta Porte Department of Environmental Chemistry, IIQAB-CSIC, Jordi Girona 18, 08034 Barcelona, Spain Aquatic Toxicology 75 (2005), 32-42. - 122 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 123 - - 124 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 125 - - 126 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 127 - - 128 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 129 - - 130 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 131 - - 132 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 133 - - 134 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 135 - Paper 6 STEROID LEVELS AND STEROID METABOLISM IN THE MUSSEL MYTILUS EDULIS: THE MODULATING EFFECT OF DISPERSED CRUDE OIL AND ALKYLPHENOLS. Ramon Lavado, Gemma Janer, Cinta Porte Department of Environmental Chemistry, IIQAB-CSIC, Jordi Girona 18, 08034 Barcelona, Spain Sumitted to Aquatic Toxicology - 136 - Chapter 3 In vivo effects of xenobiotics on steroid levels and steroid metabolism - 137 - Submitted to Aquatic Toxicology Steroid levels and steroid metabolism in the mussel Mytilus edulis: the modulating effect of dispersed crude oil and alkylphenols Ramón Lavado, Gemma Janer and Cinta Porte* Environmental Chemistry Dept. -
Discovery of High Affinity Receptors for Dityrosine Through Inverse Virtual Screening and Docking and Molecular Dynamics
Article Discovery of High Affinity Receptors for Dityrosine through Inverse Virtual Screening and Docking and Molecular Dynamics Fangfang Wang 1,*,†, Wei Yang 2,3,† and Xiaojun Hu 1,* 1 School of Life Science, Linyi University, Linyi 276000, China; [email protected] 2 Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia, [email protected] 3 Arieh Warshel Institute of Computational Biology, the Chinese University of Hong Kong, 2001 Longxiang Road, Longgang District, Shenzhen 518000, China * Corresponding author: [email protected] † These authors contributed equally to this work. Received: 09 December 2018; Accepted: 23 December 2018; Published: date Table S1. Docking affinity scores for cis-dityrosine binding to binding proteins. Target name PDB/UniProtKB Type Affinity (kcal/mol) Galectin-1 1A78/P56217 Lectin -6.2±0.0 Annexin III 1AXN/P12429 Calcium/phospholipid Binding Protein -7.5±0.0 Calmodulin 1CTR/P62158 Calcium Binding Protein -5.8±0.0 Seminal Plasma Protein Pdc-109 1H8P/P02784 Phosphorylcholine Binding Protein -6.6±0.0 Annexin V 1HAK/P08758 Calcium/phospholipid Binding -7.4±0.0 Alpha 1 antitrypsin 1HP7/P01009 Protein Binding -7.6±0.0 Histidine-Binding Protein 1HSL/P0AEU0 Binding Protein -6.3±0.0 Intestinal Fatty Acid Binding Protein 1ICN/P02693 Binding Protein(fatty Acid) -9.1±0.0* Migration Inhibitory Factor-Related Protein 14 1IRJ/P06702 Metal Binding Protein -7.0±0.0 Lysine-, Arginine-, Ornithine-Binding Protein 1LST/P02911 Amino Acid Binding Protein -6.5±0.0 -
All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA -
(12) United States Patent (10) Patent No.: US 7,611,839 B2 Twine Et Al
US00761 1839B2 (12) United States Patent (10) Patent No.: US 7,611,839 B2 Twine et al. (45) Date of Patent: Nov. 3, 2009 (54) METHODS FOR DIAGNOSING RCC AND 2002/0168638 A1 1 1/2002 Schlegel et al. OTHER SOLD TUMIORS 2002/0182614 A1 12/2002 Gillis et al. (75) I nVentors:t NatalieNatale U.C. Twine.Wine, UOIISLOWn,Goffst NH (US) 2004/0175743 A1 9/2004 Burczynski et al. Michael E. Burczynski, Swampscott, 2004/0235020 A1 1 1/2004 Burczynski et al. MA (US); William L. Trepicchio, Andover, MA (US); Andrew J. Dorner, Lexington, MA (US); Jennifer A. Stover, Topsfield, MA (US); Donna K. FOREIGN PATENT DOCUMENTS Slonim, North Andover, MA (US) WO WO 89/10134 11, 1989 (73) Assignee: Wyeth, Madison, NJ (US) WO WO 97.07668 3, 1997 WO WO 97.07669 3, 1997 (*) Notice: Subject to any disclaimer, the term of this WO WO99,14346 3, 1999 patent is extended or adjusted under 35 WO WO99,27132 6, 1999 U.S.C. 154(b) by 56 days. WO WOOOf 40749 T 2000 (21) Appl. No.: 10/717,597 WO WOOOf 44895 8, 2000 WO WOOOf 63364 10, 2000 (22) Filed: Nov. 21, 2003 WO WOO1/29058 4/2001 WO WOO1,36646 5, 2001 (65) Prior Publication Data WO WOO1? 68836 9, 2001 US 2004/O110221A1 Jun. 10, 2004 WO WOO1,70949 9, 2001 O O WO WOO1,75164 10, 2001 Related U.S. Application Data WO WOO1,81916 11, 2001 (60) Provisional application No. 60/427,982, filed on Nov. WO WOO1/92513 12/2001 21, 2002, provisional application No. -
The Effect of Diet on Midgut and Resulting Changes in Infectiousness of Acmnpv Baculovirus in Trichoplusia Ni
Western University Scholarship@Western Electronic Thesis and Dissertation Repository 9-27-2017 2:00 PM The effect of diet on midgut and resulting changes in infectiousness of AcMNPV baculovirus in Trichoplusia ni Elizabeth Chen The University of Western Ontario Supervisor Dr. Cameron Donly The University of Western Ontario Co-Supervisor Dr. Jeremy McNeil The University of Western Ontario Graduate Program in Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Science © Elizabeth Chen 2017 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Agricultural Science Commons, Cell Biology Commons, Comparative Nutrition Commons, Integrative Biology Commons, Molecular Genetics Commons, Organismal Biological Physiology Commons, Other Genetics and Genomics Commons, Pathogenic Microbiology Commons, Systems and Integrative Physiology Commons, and the Virology Commons Recommended Citation Chen, Elizabeth, "The effect of diet on midgut and resulting changes in infectiousness of AcMNPV baculovirus in Trichoplusia ni" (2017). Electronic Thesis and Dissertation Repository. 4924. https://ir.lib.uwo.ca/etd/4924 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract The cabbage looper, Trichoplusia ni, a global generalist lepidopteran pest, has developed resistance to many synthetic and biological insecticides, requiring effective and environmentally acceptable alternatives. One possibility is the Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV). This baculovirus is highly infectious for T. ni, with potential as a biocontrol agent, however, its effectiveness is strongly influenced by dietary context.